Literature DB >> 6998815

Insulin antibodies prevent insulin-receptor interactions.

R de Pirro, A Fusco, L Spallone, R Magnatta, R Lauro.   

Abstract

The study was carried out to investigate whether insulin bound to antibody is able to bind the insulin receptor of target tissues. Three specific rabbit anti-insulin sera as well as sera from eight diabetic patients with insulin antibodies were incubated, free of insulin, with labelled insulin for 48 h at 4 degrees C; following incubation labelled insulin was employed in binding experiments on monocytes, erythrocytes and placenta membranes. Using rabbit sera, receptor binding was absent when insulin was totally combined with antibody, and appeared in increasing amounts as the percentage of free insulin increased to reach a maximum when no insulin was combined with antibody. The same experiment using sera from diabetic patients showed a close negative relationship (r = 0.95) between the amount of insulin bound to the antibody and the amount bound to receptors. The influence of the insulin-antibody complex on the insulin receptor interaction was evaluated by exposing the insulin-antibody complex to the receptor in pH, temperature and competition-inhibition curve experiments. The complex had no effect on receptor affinity or on the pH and temperature relationship influence with insulin-receptor interaction. The findings suggest that insulin resistance in the presence of insulin antibodies is due only to an alteration occurring before the interaction of insulin with its receptor, and demonstrate that the insulin-antibody complex does not influence the insulin receptor interaction.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6998815     DOI: 10.1007/bf00421857

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  25 in total

Review 1.  Receptors for insulin, NSILA-s, and growth hormone: applications to disease states in man.

Authors:  J Roth; C R Kahn; M A Lesniak; P Gorden; P De Meyts; K Megyesi; D M Neville; J R Gavin; A H Soll; P Freychet; I D Goldfine; R S Bar; J A Archer
Journal:  Recent Prog Horm Res       Date:  1975

2.  Demonstration that monocytes rather than lymphocytes are the insulin-binding cells in preparations of humah peripheral blood mononuclear leukocytes: implications for studies of insulin-resistant states in man.

Authors:  R H Schwartz; A R Bianco; B S Handwerger; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

Review 3.  Receptors, antireceptor antibodies and mechanisms of insulin resistance.

Authors:  J S Flier; C R Kahn; J Roth
Journal:  N Engl J Med       Date:  1979-02-22       Impact factor: 91.245

4.  Decreased binding of insulin to its receptors in rats with hormone induced insulin resistance.

Authors:  I D Goldfine; C R Kahn; D M Neville; J Roth; M M Garrison; R W Bates
Journal:  Biochem Biophys Res Commun       Date:  1973-08-06       Impact factor: 3.575

Review 5.  Peptide hormone binding to receptors: a review of direct studies in vitro.

Authors:  J Roth
Journal:  Metabolism       Date:  1973-08       Impact factor: 8.694

6.  Modulation of binding and bioactivity of insulin by anti-insulin antibody: relation to possible role of receptor self-aggregation in hormone action.

Authors:  Y Shechter; K J Chang; S Jacobs; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

7.  The monocyte as a model for the study of insulin receptors in man.

Authors:  H Beck-Nielsen; O Pedersen; K Kragballe; N S Sorensen
Journal:  Diabetologia       Date:  1977-12       Impact factor: 10.122

8.  Specificities of rabbit anti-human insulin receptor antibodies.

Authors:  R De Pirro; R Lauro; A S Gelli; A Bertoli; P Musiani
Journal:  J Clin Lab Immunol       Date:  1979-04

9.  Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.

Authors:  J M Olefsky
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

10.  Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors.

Authors:  R S Bar; W R Levis; M M Rechler; L C Harrison; C Siebert; J Podskalny; J Roth; M Muggeo
Journal:  N Engl J Med       Date:  1978-05-25       Impact factor: 91.245

View more
  8 in total

Review 1.  Insulin-dependent (type I) diabetes mellitus.

Authors:  W Rodger
Journal:  CMAJ       Date:  1991-11-15       Impact factor: 8.262

2.  Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics.

Authors:  R S Gray; P Cowan; U di Mario; R A Elton; B F Clarke; L J Duncan
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-08

3.  The effect of insulin antibodies on insulin dose and diabetic control.

Authors:  S Walford; S P Allison; W G Reeves
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

Review 4.  The new insulins. Their characteristics and clinical indications.

Authors:  P D Home; K G Alberti
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

5.  Insulin antibodies induced by bovine insulin therapy.

Authors:  W G Reeves; U Kelly
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

6.  Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices.

Authors:  N Jeandidier; S Boivin; R Sapin; F Rosart-Ortega; B Uring-Lambert; P Réville; M Pinget
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

7.  Abnormal carbohydrate metabolism in a canine model for muscular dystrophy.

Authors:  Andressa R Amaral; Márcio A Brunetto; Marina P Brólio; Daniela S Cima; Maria A Miglino; João Paulo F Santos; Carlos E Ambrósio
Journal:  J Nutr Sci       Date:  2017-11-23

8.  Increased C-Peptide Immunoreactivity in Insulin Autoimmune Syndrome (Hirata Disease) Due to High Molecular Weight Proinsulin.

Authors:  Richard G Kay; Peter Barker; Keith Burling; Mark Cohen; David Halsall; Frank Reimann; Fiona M Gribble; Robert K Semple; David Church
Journal:  Clin Chem       Date:  2021-06-01       Impact factor: 8.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.